Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma
S Xiaohong, L Huikai, W Feng, Z Ti, C Yunlong… - World journal of …, 2010 - Springer
Background There are few detailed clinical reports about perihepatic lymph node (LN)
assessment of hepatocellular carcinoma (HCC). The purpose of the present study was to evaluate …
assessment of hepatocellular carcinoma (HCC). The purpose of the present study was to evaluate …
Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic …
…, T Song, T Zhang, Q Wu, Y Cui, H Li, W Zhang, Q Li - BMC cancer, 2020 - Springer
Background Isocitrate dehydrogenase 1/2 (IDH1/2), BAP1, ARID1A and PBRM1 have been
reported as the most frequent mutant genes in intrahepatic cholangiocarcinoma (ICC), and …
reported as the most frequent mutant genes in intrahepatic cholangiocarcinoma (ICC), and …
Delivering microstructural complexity to additively manufactured metals through controlled mesoscale chemical heterogeneity
H Li, S Thomas, C Hutchinson - Acta Materialia, 2022 - Elsevier
Laser powder bed fusion (LPBF) of metals is a popular mode of additive manufacturing (AM)
that has the advantage of producing complex shapes with little or no additional processing. …
that has the advantage of producing complex shapes with little or no additional processing. …
[HTML][HTML] Predicting the chemical homogeneity in laser powder bed fusion (LPBF) of mixed powders after remelting
H Li, EG Brodie, C Hutchinson - Additive Manufacturing, 2023 - Elsevier
An advantage of laser powder bed fusion (LPBF) of metals is that one can create topologically
complex components with comparative ease. Most LPBF studies use commercial pre-…
complex components with comparative ease. Most LPBF studies use commercial pre-…
Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
…, H Li, Y Cui, F Fang, W Zhang, T Song, Q Li… - Journal of hematology & …, 2016 - Springer
Background Sorafenib is recognized as a standard treatment for advanced hepatocellular
carcinoma (HCC). However, many patients have to adopt dose reduction or terminate the use …
carcinoma (HCC). However, many patients have to adopt dose reduction or terminate the use …
[HTML][HTML] Apatinib is effective for treatment of advanced hepatocellular carcinoma
…, Y Zhang, P Chen, Y Cui, X Zhu, T Song, Q Li, H Li… - Oncotarget, 2017 - ncbi.nlm.nih.gov
As treatment options for hepatocellular carcinoma (HCC) are currently limited, we evaluated
the efficacy and safety of oral apatinib, a VEGFR-2 inhibitor, on patients with advanced HCC…
the efficacy and safety of oral apatinib, a VEGFR-2 inhibitor, on patients with advanced HCC…
Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a …
…, Q Zou, Z Guo, X Yang, M Li, D Liu, H Mu, H Li… - Frontiers in …, 2023 - frontiersin.org
Background Molecular targeted therapy combined with immunotherapy significantly improves
the prognosis of patients with advanced liver cancer. Additionally, hepatic arterial infusion …
the prognosis of patients with advanced liver cancer. Additionally, hepatic arterial infusion …
Research progress in reversal of tumor multi-drug resistance via natural products
Q Guo, H Cao, X Qi, H Li, P Ye, Z Wang… - Anti-Cancer Agents …, 2017 - ingentaconnect.com
Multidrug resistance occurs when a tumor develops resistance to multiple chemotherapeutic
drugs, which may include antitumor drugs with different chemical structures and …
drugs, which may include antitumor drugs with different chemical structures and …
Clinicopathological and prognostic features of primary clear cell carcinoma of the liver
Z Liu, W Ma, H Li, Q Li - Hepatology Research, 2008 - Wiley Online Library
Aim: Primary clear cell carcinoma of the liver (PCCCL) is a subgroup of primary hepatocellular
carcinoma (HCC), pathologically characterized by diffuse clear cells of the tumor, showing …
carcinoma (HCC), pathologically characterized by diffuse clear cells of the tumor, showing …
Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience
H Li, Y Qin, Y Cui, H Chen, X Hao, Q Li - Digestive Surgery, 2011 - karger.com
Purposes: Hilar cholangiocarcinoma (HC) is the most common location for bile duct cancer.
It represents a significant technical challenge for surgical operation due to the close …
It represents a significant technical challenge for surgical operation due to the close …
